Poland’s Ultimo SA Uses FICO AI-Powered Optimization to Advance Ethical Debt Resolution
Ultimo SA, one of the largest debt management companies in Poland and a part of B2 Holdings, will use FICO collections treatment optimization to take the ideal treatment path for each borrower. Using advanced mathematical optimization from FICO, Ultimo will be able to identify the best, most sustainable collections strategy for each borrower, from among dozens or even hundreds of potential options.
“Our mission is to help people get out of debt,” said Marek Czystołowski, Chief Operating Officer at Ultimo. “We are members of the Association of Financial Companies in Poland, we follow the Association’s Principles of Good Debt Collection Practices, and each year we receive the Association’s Ethical Audit Certificate. As an ethical debt management agency, we need the best way to serve our financial services partners and their customers, and using FICO’s advanced data science will help us do just that. We are complementing Ultimo’s market-leading collections expertise with innovative data science.”
“Debt remediation is at the forefront of the financial services industry’s response to the pandemic,” said Jens Dauner, vice president of FICO overseeing the DACH region and Central Europe. “We are proud to support Ultimo’s ethical debt resolution with our AI-powered optimization. There has never been a more important time to ensure every collections decision is the best possible decision.”
Collections optimization helps organizations of all sizes strike a balance between loss reduction, resource challenges, and operational constraints to help maximize profitability, meet regulatory requirements, and manage customer satisfaction. It can be leveraged across the collections spectrum — from pre-delinquency and early stage collections through later stage and recovery activities. Using collections optimization, lenders and debt collection agencies can easily and confidently choose the best decisions for account placements, settlements, channel selection, and other strategic treatment decisions.